Clinical News: Page 1059

Future of personalized medicine; cardiac CT for calcium scoring; MR-guided biopsies
By Philip Ward
October 11, 2011
Definiens provides boost for biomarkers
By AuntMinnieEurope.com staff writers
Imaging software developer Definiens has announced the release of its quantitative digital pathology portfolio designed to advance translational research in pathology, specifically biomarker development.
October 11, 2011
ESR focuses attention on personalized medicine
By Philip Ward
The era of personalized medicine has major implications for medical imaging and will bring considerable changes in the years ahead, predicts a European Society of Radiology (ESR) white paper. Find out more in our news report.
October 11, 2011
2011 10 12 11 09 04 145 Padhani Esr 12oct11 Thumb
Germans act creatively to make MR-guided biopsies viable
By Philip Ward
MR-guided biopsies can produce valuable results, but often they are time-consuming and expensive. To make them a more realistic clinical proposition, it is vital to cut the preparation time, obtain fewer image acquisitions, and involve experienced interventional radiologists, researchers from the University of Tübingen in Germany have reported.
October 11, 2011
2011 10 11 12 39 08 432 2011 10 12 Hoffmann Thumb
Study: CT calcium screening cost-effective only in men
By Eric Barnes
CT-based coronary artery calcium screening in individuals at intermediate risk of heart disease is probably cost-effective for men but not women, according to an extensive new study from the Netherlands.
October 11, 2011
2011 10 11 10 17 59 393 2011 10 12 Thumb
USARad.com to expand telerad service globally
By AuntMinnieEurope.com staff writers
Teleradiology services provider USARad.com has launched its WorldRad.com division to service and position the company in the international marketplace.
October 10, 2011
Agfa rebrands contrast business
By AuntMinnieEurope.com staff writers
Agfa HealthCare is changing the name of Insight Agents, a German contrast media developer it acquired in January 2010, to Agfa HealthCare Imaging Agents.
October 10, 2011
Low-dose DR units can avoid need for gonad shielding
By Cynthia E. Keen
Gonad shielding of children who undergo a pelvic examination may not be necessary if low-dose optimized digital radiography (DR) equipment is used, according to a new study by Dutch researchers published online in Insights into Imaging.
October 10, 2011
Agfa launches new nuclear medicine PACS
By AuntMinnieEurope.com staff writers
Agfa Healthcare is using the venue of the 2011 Congress of the European Association of Nuclear Medicine later this week to introduce the newest version of its Impax for Nuclear Medicine PACS.
October 9, 2011
OctreoPharm signs deal with Novartis
By AuntMinnieEurope.com staff writers
German nuclear medicine contrast company OctreoPharm Sciences has received the worldwide exclusive license for the development and commercialization of SOMscan from Novartis Pharma.
October 9, 2011
CTA detects coronary artery anomalies in Singapore
By Philip Ward
An extensive study of the local population in Singapore has found that the incidence of coronary artery anomalies detected by CT angiography (CTA) is greater than has been reported elsewhere in the medical literature.
October 9, 2011
2011 10 07 15 18 39 257 Singapore 70
Europeans played key role in early days of contrast media
By Dr. Adrian Thomas
When you administer your next dose of contrast media, spare a thought for Dr. Torsten Almén from Sweden and others who did the important early development work. Our history columnist, Dr. Adrian Thomas, looks at the evidence.
October 9, 2011
2011 10 07 14 25 05 705 2011 10 10 Torsten Alme 70
Previous Page
Page 1059 of 1310
Next Page